Fonar Return on Tangible Equity 2010-2024 | FONR

Current and historical return on tangible equity values for Fonar (FONR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Fonar Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-12-31 $0.01B $0.15B 5.31%
2024-09-30 $0.01B $0.15B 6.66%
2024-06-30 $0.01B $0.15B 7.39%
2024-03-31 $0.01B $0.15B 7.48%
2023-12-31 $0.01B $0.15B 8.95%
2023-09-30 $0.01B $0.15B 7.69%
2023-06-30 $0.01B $0.14B 6.37%
2023-03-31 $0.01B $0.14B 7.14%
2022-12-31 $0.01B $0.14B 5.79%
2022-09-30 $0.01B $0.14B 7.31%
2022-06-30 $0.01B $0.14B 8.91%
2022-03-31 $0.01B $0.14B 8.33%
2021-12-31 $0.01B $0.13B 10.04%
2021-09-30 $0.01B $0.13B 9.45%
2021-06-30 $0.01B $0.13B 8.05%
2021-03-31 $0.01B $0.13B 8.20%
2020-12-31 $0.01B $0.12B 5.85%
2020-09-30 $0.01B $0.12B 5.93%
2020-06-30 $0.01B $0.12B 6.87%
2020-03-31 $0.01B $0.12B 9.63%
2019-12-31 $0.01B $0.12B 12.58%
2019-09-30 $0.01B $0.11B 13.05%
2019-06-30 $0.01B $0.11B 13.56%
2019-03-31 $0.02B $0.11B 19.14%
2018-12-31 $0.02B $0.10B 19.20%
2018-09-30 $0.02B $0.10B 21.47%
2018-06-30 $0.02B $0.09B 22.96%
2018-03-31 $0.02B $0.08B 20.65%
2017-12-31 $0.02B $0.08B 26.03%
2017-09-30 $0.02B $0.08B 28.15%
2017-06-30 $0.02B $0.07B 30.40%
2017-03-31 $0.02B $0.07B 33.33%
2016-12-31 $0.02B $0.06B 30.33%
2016-09-30 $0.02B $0.06B 30.15%
2016-06-30 $0.02B $0.05B 32.09%
2016-03-31 $0.01B $0.05B 31.64%
2015-12-31 $0.01B $0.05B 31.52%
2015-09-30 $0.01B $0.04B 30.38%
2015-06-30 $0.01B $0.04B 29.14%
2015-03-31 $0.01B $0.04B 27.59%
2014-12-31 $0.01B $0.04B 28.57%
2014-09-30 $0.01B $0.04B 30.77%
2014-06-30 $0.01B $0.03B 33.06%
2014-03-31 $0.01B $0.03B 36.04%
2013-12-31 $0.01B $0.03B 35.64%
2013-09-30 $0.01B $0.03B 38.55%
2013-06-30 $0.01B $0.02B 43.08%
2013-03-31 $0.00B $0.02B 33.33%
2012-12-31 $0.00B $0.01B 47.06%
2012-09-30 $0.00B $0.01B 57.14%
2012-06-30 $0.00B $0.01B 72.73%
2012-03-31 $0.00B $0.01B 70.59%
2011-12-31 $0.00B $0.01B 240.00%
2011-09-30 $0.00B $0.00B -150.00%
2011-06-30 $0.00B $0.00B -40.00%
2011-03-31 $0.00B $-0.01B -25.00%
2010-12-31 $0.00B $-0.01B -10.53%
2010-09-30 $-0.00B $-0.01B 9.76%
2010-06-30 $-0.00B $-0.01B 28.57%
2010-03-31 $-0.00B $-0.01B 30.00%
2009-12-31 $-0.00B $-0.01B 21.62%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.087B $0.103B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.058B 28.41
Boston Scientific (BSX) United States $149.209B 40.19
Stryker (SYK) United States $142.084B 30.54
EssilorLuxottica (ESLOY) France $131.854B 0.00
Medtronic (MDT) Ireland $115.249B 16.83
Haleon (HLN) United Kingdom $46.488B 26.39
Lonza Group Ag (LZAGY) Switzerland $44.527B 0.00
GE HealthCare Technologies (GEHC) United States $36.909B 17.98
Agilent Technologies (A) United States $33.351B 22.03
ResMed (RMD) United States $32.876B 25.32
Terumo (TRUMY) Japan $27.805B 39.54
Koninklijke Philips (PHG) Netherlands $23.874B 17.05
Zimmer Biomet Holdings (ZBH) United States $22.530B 14.15
Insulet (PODD) United States $18.442B 78.86
Baxter (BAX) United States $17.557B 12.63
Sunny Optical Technology (SNPTF) China $12.864B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $12.403B 0.00
Demant (WILYY) Denmark $8.048B 0.00
Bio-Rad Laboratories (BIO) United States $6.822B 23.62
Lantheus Holdings (LNTH) United States $6.684B 16.43
Prestige Consumer Healthcare (PBH) United States $4.259B 20.32
Perrigo (PRGO) Ireland $3.826B 10.95
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.405B 29.11
Haemonetics (HAE) United States $3.193B 15.02
Envista Holdings (NVST) United States $2.972B 23.64
QuidelOrtho (QDEL) United States $2.359B 19.76
GN Store Nord (GNNDY) Denmark $2.336B 15.74
LeMaitre Vascular (LMAT) United States $1.893B 43.25
Neogen (NEOG) United States $1.881B 21.67
AtriCure (ATRC) United States $1.577B 0.00
AdaptHealth (AHCO) United States $1.462B 14.08
Kestra Medical Technologies (KMTS) $1.234B 0.00
InMode (INMD) Israel $1.234B 10.31
Green Thumb Industries (GTBIF) United States $1.233B 19.37
BioLife Solutions (BLFS) United States $1.073B 0.00
Phibro Animal Health (PAHC) United States $0.865B 13.27
Evolus (EOLS) United States $0.765B 0.00
Owens & Minor (OMI) United States $0.698B 5.94
CeriBell (CBLL) United States $0.689B 0.00
Curaleaf Holdings (CURLF) Canada $0.601B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.562B 0.00
Valneva SE (VALN) France $0.545B 0.00
VAREX IMAGING (VREX) United States $0.478B 20.71
Omeros (OMER) United States $0.476B 0.00
Surmodics (SRDX) United States $0.436B 0.00
Capricor Therapeutics (CAPR) United States $0.433B 0.00
SNDL (SNDL) Canada $0.371B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Sanuwave Health (SNWV) United States $0.302B 0.00
ZimVie (ZIMV) United States $0.301B 18.00
Viemed Healthcare (VMD) United States $0.288B 26.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Cerus (CERS) United States $0.258B 0.00
Quanterix (QTRX) United States $0.252B 0.00
OraSure Technologies (OSUR) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.247B 43.90
Verano Holdings (VRNOF) United States $0.233B 0.00
Utah Medical Products (UTMD) United States $0.184B 14.19
Biote (BTMD) United States $0.182B 4.16
Brainsway (BWAY) Israel $0.178B 55.71
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
High Tide (HITI) Canada $0.153B 0.00
Canopy Growth (CGC) Canada $0.144B 0.00
TerrAscend (TSNDF) Canada $0.140B 0.00
Organigram Holdings (OGI) Canada $0.128B 0.00
Jin Medical (ZJYL) China $0.116B 0.00
FitLife Brands (FTLF) United States $0.112B 13.99
Quipt Home Medical (QIPT) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
MacroGenics (MGNX) United States $0.080B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.067B 24.44
United Health Products (UEEC) United States $0.066B 0.00
Exagen (XGN) United States $0.064B 0.00
InterCure (INCR) Israel $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Modular Medical (MODD) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
United-Guardian (UG) United States $0.041B 12.66
Rockwell Medical (RMTI) United States $0.038B 56.50
Safety Shot (SHOT) United States $0.027B 0.00
INLIF (INLF) $0.021B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00